SCHEMBL6826835

SCHEMBL6826835

FC(F)c1ccncn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30184838 1.00
SCHEMBL7123634 0.81
SCHEMBL28139368 0.81
SCHEMBL9484430 0.77
SCHEMBL7703784 0.76 HSP90AA1 (0.35)
SCHEMBL11876642 0.75
SCHEMBL84451 0.75
SCHEMBL29448509 0.75
SCHEMBL4263709 0.75
Water SCHEMBL8524004 0.73 HSP90AA1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025132758-A1 PESTICIDALLY ACTIVE QUINAZOLINE COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2025-06-26 WO disclosed
WO-2025132349-A1 PESTICIDALLY ACTIVE QUINAZOLINE COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2025-06-26 WO disclosed
WO-2024099478-A1 INHALABLE AROMATIC RING THIAZIDE AND ANALOG, PHARMACEUTICAL COMPOSITION CONTAINING INHALABLE AROMATIC RING THIAZINE, AND USE OF INHALABLE AROMATIC RING THIAZINE IN ANTI-INFLAMMATION AND ANTI-TUMOR 杭州百诚医药科技股份有限公司 2024-05-16 WO disclosed
CN-117088867-A Inhalable aromatic ring thiazide and analogue, pharmaceutical composition containing inhalable aromatic ring thiazide and analogue and application of inhalable aromatic ring thiazide and analogue in anti-inflammatory and anti-tumor 杭州百诚医药科技股份有限公司 2023-11-21 CN disclosed
EP-4017590-A1 PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS Galapagos N.V. (BE) 2022-06-29 EP disclosed
CN-109906224-A TRIAZOLOPYRIDINE COMPOUNDS AND USES THEREOF 诺华股份有限公司 2019-06-18 CN disclosed
CN-106456639-B Prodrugs of HIV Reverse Transcriptase Inhibitors 默沙东公司 2019-05-10 CN disclosed
CN-109414415-A The treatment of cutaneous lesions 皮奎尔治疗公司 2019-03-01 CN disclosed
CN-104822670-B 5-phenoxy-3H-pyrimidin-4-one derivatives and their use as HIV reverse transcriptase inhibitors 默沙东公司 2018-01-12 CN disclosed
CN-107108644-A Difluoromethyl aminopyridine and difluoromethyl aminopyrimidine 皮奎尔治疗公司 2017-08-29 CN disclosed
CN-106456639-A Prodrugs of hiv reverse transcriptase inhibitors 默沙东公司 2017-02-22 CN disclosed
CN-105473572-A Herbicidal compounds SYNGENTA LTD 2016-04-06 CN disclosed
CN-104902751-A Method for promoting plant growth SUMITOMO CHEMICAL CO 2015-09-09 CN disclosed
CN-104902750-A Method for promoting plant growth SUMITOMO CHEMICAL CO 2015-09-09 CN disclosed
CN-104902752-A Method for promoting plant growth SUMITOMO CHEMICAL CO 2015-09-09 CN disclosed
CN-104902749-A Method for promoting plant growth SUMITOMO CHEMICAL CO 2015-09-09 CN disclosed
EP-2903977-A1 5-PHENOXY-3H-PYRIMIDIN-4-ONE DERIVATIVES AND THEIR USE AS HIV REVERSE TRANSCRIPTASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2015-08-12 EP disclosed
WO-2014058747-A1 5-PHENOXY-3H-PYRIMIDIN-4-ONE DERIVATIVES AND THEIR USE AS HIV REVERSE TRANSCRIPTASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2014-04-17 WO disclosed
CN-101384263-A Is suitable for treating dopamine D3Triazole compounds for receptor-mediated diseases ABBOTT GMBH & CO KG (DE) 2009-03-11 CN disclosed
WO-2004108706-A1 TRIAZOLE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO. KG (DE) 2004-12-16 WO disclosed